Loading organizations...
§ Private Profile · London, United Kingdom
Health-tech platform connecting patients with verified healthcare providers via reviews and endorsements, helping doctors manage reputation.
Doctify has raised $25.5M across 3 funding rounds.
Key people at Doctify.
Doctify has raised $25.5M in total across 3 funding rounds.
London-based Doctify operates a health-tech platform that connects patients with verified healthcare providers through a centralized system of patient reviews and professional endorsements. The company utilizes a subscription-based business model that allows medical professionals, hospitals, and clinics to access reputation management tools and patient feedback services. Operating across six international markets with a workforce of over 100 employees, the platform has served more than 50 million patients and currently lists over 150,000 healthcare providers. The enterprise has secured $7.5 million in total funding across two rounds, generating approximately $21 million in revenue while capturing 93 percent of private hospitals in Greater London. The platform maintains active enterprise partnerships with recognizable healthcare organizations including HCA Healthcare UK, Vitality Health, and the NHS. Doctify was founded in 2015 by Stephanie Eltz and Suman Saha.
Key people at Doctify.
Doctify has raised $25.5M across 3 funding rounds. Most recently, it raised $10.0M Other Equity in February 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 2, 2023 | $10M Venture Round | Carrie Babcock | Amadeus Capital Partners, Guinness Asset Management, Keen Venture Partners | Announced |
| Apr 13, 2021 | $7.5M Venture Round | Briehan Burke | Thomas Teichman, Amadeus Capital Partners, Guinness Asset Management | Announced |
| Apr 1, 2021 | $8M Series U | — | Nigel Wray | Announced |
# Doctify: Healthcare Review Platform
Doctify is a healthcare technology company that builds a SaaS platform enabling patients to access verified reviews of doctors, hospitals, and clinics while providing healthcare providers with tools to collect patient feedback and manage their reputation.[1][2] Founded in 2015 by two NHS surgeons, the company operates across six markets—the UK, Ireland, Austria, Germany, Australia, and the UAE—with an ambitious mission to help 100 million patients confidently choose their healthcare by 2025.[3][5]
The platform solves a fundamental transparency problem in healthcare: patients historically lacked access to reliable, representative feedback about specialists and providers, while healthcare professionals struggled to collect meaningful patient insights at scale.[5] Doctify addresses this by digitizing patient feedback into structured, condition-specific reviews that appear across multiple channels, while simultaneously providing providers with analytics to drive patient-centric care improvements.[1]
Doctify was founded in 2015 by Stephanie Eltz and Suman Saha, both orthopaedic surgeons working in the NHS.[4][5] The co-founders recognized a critical gap: the feedback available to patients was outdated, unrepresentative, and poorly suited to healthcare's complexity, while providers lacked systematic ways to understand patient experiences.[5] Rather than accept this status quo, they leveraged their clinical expertise to build a dedicated healthcare review platform.
The company achieved remarkable early traction, becoming revenue-generating within less than a year of launch.[1] This rapid validation attracted backing from prominent European venture capital firms—Amadeus Capital and Keen Ventures—alongside notable angel investors including Sir John Hegarty (founder of Saatchi and Saatchi) and Tom Teichmann (early backer of Lastminute.com, Not on the Highstreet, and Made.com).[1] By the time of these search results, Doctify had onboarded over 25,000 doctors, hospitals, and clinics across its operating markets and expanded its team across six countries.[1]
Doctify operates at the intersection of healthcare digitization, patient empowerment, and AI-driven discovery. As artificial intelligence increasingly mediates how patients search for healthcare, platforms with verified, structured data become essential infrastructure.[7] Doctify's verified reviews and validated provider information position healthcare professionals to be reliably recognized and surfaced in AI-powered patient recommendations—a competitive advantage as search behavior evolves.[7]
The company also rides the broader trend toward transparency and trust in professional services. Just as platforms like Glassdoor transformed employment visibility and TripAdvisor changed travel, Doctify is establishing similar accountability in healthcare—a sector historically opaque to patients. This aligns with regulatory and consumer pressure for greater healthcare transparency globally.
Doctify's expansion into six markets and partnerships with major institutional players suggest the company has moved beyond early-stage validation into sustainable growth. The 2025 mission target of helping 100 million patients choose healthcare reflects ambition, though achieving this would require significant acceleration from current penetration levels.
The company's future likely hinges on three factors: geographic expansion (the stated desire to operate worldwide), deepening institutional partnerships (replicating the HCA and Vitality successes), and AI integration (ensuring Doctify remains the trusted data source as patient discovery becomes AI-mediated). As healthcare systems globally grapple with quality measurement and patient-centered care mandates, Doctify's core value proposition—turning patient voice into actionable intelligence—becomes increasingly relevant.
The timing favors platforms that solve trust and transparency problems in regulated industries. Doctify's clinical founders and proven ability to scale across diverse healthcare markets position it well to become the global standard for healthcare provider credibility.
Doctify has raised $25.5M in total across 3 funding rounds.
Doctify's investors include Carrie Babcock, Amadeus Capital Partners, Guinness Asset Management, Keen Venture Partners, Briehan Burke, Thomas Teichman, Nigel Wray.
